⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5427936 | 1.00 | — | — | |
| SCHEMBL4711905 | 1.00 | — | — | |
| SCHEMBL19711770 | 0.74 | KMT2A (0.47) | — | |
| SCHEMBL22045856 | 0.74 | KMT2A (0.47) | — | |
| SCHEMBL4181392 | 0.72 | — | — | |
| SCHEMBL2021592 | 0.72 | — | — | |
| SCHEMBL3255643 | 0.72 | — | — | |
| SCHEMBL9708934 | 0.72 | — | — | |
| SCHEMBL10182573 | 0.72 | — | — | |
| SCHEMBL23697812 | 0.72 | CYP19A1 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3494106-B1 | PROCESSES FOR MAKING, AND METHODS OF USING, GLYCOPYRRONIUM COMPOUNDS | JOURNEY MEDICAL CORP (US) | 2022-07-20 | — | — | EP | disclosed |
| US-11352323-B2 | Processes for making, and methods of using, glycopyrronium compounds | JOURNEY MEDICAL CORPORATION (US) | 2022-06-07 | — | — | US | disclosed |
| US-20210130289-A1 | PROCESSES FOR MAKING, AND METHODS OF USING, GLYCOPYRRONIUM COMPOUNDS | SWK FUNDING LLC | 2021-05-06 | — | — | US | disclosed |
| US-10906871-B2 | Processes for making, and methods of using, glycopyrronium compounds | DERMIRA, INC. (US) | 2021-02-02 | — | — | US | disclosed |
| US-20190161443-A1 | PROCESSES FOR MAKING, AND METHODS OF USING, GLYCOPYRRONIUM COMPOUNDS | SWK FUNDING LLC | 2019-05-30 | — | — | US | disclosed |
| US-9630934-B2 | Fumarate compounds, pharmaceutical compositions thereof, and methods of use | Nguyen, Mark Quang (US) | 2017-04-25 | — | — | US | disclosed |
| EP-2885294-B1 | SYNTHESIS OF AN ANTIVIRAL COMPOUND | GILEAD SCIENCES INC (US) | 2016-11-30 | — | — | EP | disclosed |
| WO-2016127186-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | NGUYEN MARK QUANG (US) | 2016-08-11 | — | — | WO | disclosed |
| US-20160229819-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | Nguyen, Mark Quang (US) | 2016-08-11 | — | — | US | disclosed |
| US-9045462-B2 | Synthesis of an antiviral compound | GILEAD SCIENCES, INC. (US) | 2015-06-02 | — | — | US | disclosed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | disclosed |
| US-5266728-A | Method for producing optically active 3-substituted-2-norbornanones and their intermediates | CHISSO CORPORATION (JP) | 1993-11-30 | — | — | US | disclosed |
| EP-0528694-A2 | Method for producing optically active 3-substituted-2-norbornanones and their intermediates | CHISSO CORPORATION (JP) | 1993-02-24 | — | — | EP | disclosed |
| US-4812565-A | ANTIHISTAMINE INTERMEDIATES | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-03-14 | — | — | US | disclosed |
| US-4810795-A | ANTIHISTAMINES | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-03-07 | — | — | US | disclosed |
| US-4727152-A | Intermediates useful in the preparation of fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof | A. H. ROBINS COMPANY, INC. (US) | 1988-02-23 | — | — | US | disclosed |
| US-4705853-A | ANTIHISTAMINES | A. H. ROBINS COMPANY, INC. (US) | 1987-11-10 | — | — | US | disclosed |
| US-4642343-A | ANTIHISTAMINES | A. H. ROBINS COMPANY, INCORPORATED (US) | 1987-02-10 | — | — | US | disclosed |
| US-4604388-A | Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof in a method of counteracting histamine | A. H. ROBINS COMPANY, INCORPORATED (US) | 1986-08-05 | — | — | US | disclosed |
| US-4592866-A | Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof | A. H. ROBINS COMPANY, INC. (US) | 1986-06-03 | — | — | US | disclosed |